Sequoia Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sequoia Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	4,527 +389	+9%	+$85.2K	0.01%	906
2026 Q1	$782K	Buy	4,138 +151	+4%	+$26.4K	﹤0.01%	1009
2025 Q4	$678K	Sell	3,987 -606	-13%	-$92.9K	﹤0.01%	1099
2025 Q3	$605K	Buy	+4,593	New	+$551K	﹤0.01%	1036
2023 Q2	–	Sell	-1,376	Closed	-$201K	–	980
2023 Q1	$201K	Buy	1,376 +74	+6%	+$10.9K	﹤0.01%	765
2022 Q4	$207K	Buy	+1,302	New	+$191K	0.01%	719

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Sequoia Financial Advisors's JAZZ Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 9.4% in Q2 2026, buying an estimated $85.2K and bringing the position to 4,527 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #906.

Sequoia Financial Advisors first reported a position in JAZZ in Q4 2022 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Sequoia Financial Advisors held 4,527 shares of Jazz Pharmaceuticals worth $1.09M as of Q2 2026.
Sequoia Financial Advisors bought 389 Jazz Pharmaceuticals shares in Q2 2026, an estimated $85.2K.
Jazz Pharmaceuticals made up 0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #906 holding.
Sequoia Financial Advisors first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.